About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Tumor-specific T Cells in Lung Cancer

Tumor-specific T Cells in Lung Cancer

NCT02515760·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital Heidelberg

With

German Cancer Research Center
Heidelberg University

Age

18–79

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Patients with histology proven non-small cell lung cancer or a lesion suspicious of non-small cell lung cancer (lung cancer group)
Healthy donors (control group)
written informed consent

You may not be if

Autoimmune disease
Patients receiving immunomodulatory drugs, e.g. tacrolimus
Prior malignancy
Pregnancy

The record

StatusActive not recruiting

PhaseNo phase

Taking part120

StartedFeb 2014

UpdatedDec 12, 2024

Conditions

Non-small Cell Lung Cancer

Where1

Division of Thoracic Surgery, Technical University of Munich, Munich, Germany
Munich, Germany